A detailed history of Azzad Asset Management Inc /Adv transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 54,605 shares of EW stock, worth $3.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
54,605
Previous 55,207 1.09%
Holding current value
$3.6 Million
Previous $5.1 Billion 29.34%
% of portfolio
0.4%
Previous 0.6%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$59.7 - $93.78 $35,939 - $56,455
-602 Reduced 1.09%
54,605 $3.6 Billion
Q2 2024

Jul 30, 2024

SELL
$84.3 - $94.31 $17,955 - $20,088
-213 Reduced 0.38%
55,207 $5.1 Billion
Q1 2024

Apr 19, 2024

SELL
$72.54 - $95.56 $2,974 - $3,917
-41 Reduced 0.07%
55,420 $5.3 Billion
Q4 2023

Apr 01, 2024

BUY
$61.71 - $77.76 $87,689 - $110,496
1,421 Added 2.63%
55,461 $4.23 Billion
Q3 2023

Apr 01, 2024

BUY
$69.28 - $93.38 $366,560 - $494,073
5,291 Added 10.85%
54,040 $3.74 Billion
Q2 2023

Apr 01, 2024

BUY
$81.41 - $94.33 $5,617 - $6,508
69 Added 0.14%
48,749 $4.6 Billion
Q1 2023

Apr 01, 2024

BUY
$74.26 - $84.51 $23,688 - $26,958
319 Added 0.66%
48,680 $4.03 Billion
Q4 2022

Apr 01, 2024

SELL
$68.3 - $87.44 $806,144 - $1.03 Million
-11,803 Reduced 19.62%
48,361 $3.61 Billion
Q3 2022

Apr 01, 2024

BUY
$82.37 - $107.29 $37,890 - $49,353
460 Added 0.77%
60,164 $4.74 Billion
Q2 2022

Apr 01, 2024

BUY
$86.5 - $128.27 $1.48 Million - $2.2 Million
17,152 Added 40.31%
59,704 $5.24 Billion
Q1 2022

Apr 01, 2024

BUY
$101.96 - $128.34 $90,234 - $113,580
885 Added 2.12%
42,552 $5.01 Billion
Q4 2021

Apr 01, 2024

BUY
$106.37 - $130.68 $14,679 - $18,033
138 Added 0.33%
41,667 $5.4 Billion
Q3 2021

Apr 01, 2024

BUY
$102.91 - $122.75 $44,148 - $52,659
429 Added 1.04%
41,529 $4.7 Billion
Q2 2021

Apr 01, 2024

BUY
$83.84 - $104.76 $29,511 - $36,875
352 Added 0.86%
41,100 $4.26 Billion
Q1 2021

Apr 01, 2024

BUY
$78.68 - $90.67 $22,817 - $26,294
290 Added 0.72%
40,748 $3.41 Billion
Q4 2020

Apr 01, 2024

BUY
$71.69 - $91.23 $179,368 - $228,257
2,502 Added 6.59%
40,458 $3.69 Billion
Q3 2020

Apr 01, 2024

BUY
$67.19 - $87.44 $1.42 Million - $1.84 Million
21,098 Added 125.15%
37,956 $3.03 Billion
Q2 2020

Apr 01, 2024

BUY
$57.54 - $76.95 $653,424 - $873,844
11,356 Added 206.4%
16,858 $1.17 Billion
Q1 2020

Apr 01, 2024

SELL
$52.41 - $81.0 $879,806 - $1.36 Million
-16,787 Reduced 75.32%
5,502 $1.04 Billion
Q4 2019

Apr 01, 2024

BUY
$71.7 - $82.09 $1,864 - $2,134
26 Added 0.12%
22,289 $2.43 Billion
Q3 2019

Apr 01, 2024

BUY
$61.55 - $75.43 $623,501 - $764,105
10,130 Added 83.49%
22,263 $2.35 Billion
Q2 2019

Apr 01, 2024

BUY
$55.74 - $64.41 $676,293 - $781,486
12,133 New
12,133 $2.24 Billion
Q1 2019

Apr 01, 2024

SELL
$47.89 - $64.05 $576,835 - $771,482
-12,045 Closed
0 $0
Q4 2018

Apr 01, 2024

SELL
$46.41 - $56.94 $16,289 - $19,985
-351 Reduced 2.83%
12,045 $1.84 Billion
Q3 2018

Apr 01, 2024

SELL
$45.7 - $58.03 $2,650 - $3,365
-58 Reduced 0.47%
12,396 $2.16 Billion
Q2 2018

Apr 01, 2024

BUY
$42.45 - $51.3 $528,672 - $638,890
12,454 New
12,454 $1.81 Billion
Q1 2018

Apr 03, 2024

BUY
$37.19 - $47.45 $28,078 - $35,824
755 Added 12.9%
6,609 $922 Million
Q4 2017

Apr 03, 2024

BUY
$33.79 - $39.39 $65,991 - $76,928
1,953 Added 50.06%
5,854 $660 Million
Q3 2017

Apr 03, 2024

SELL
$36.29 - $38.83 $1.87 Million - $2 Million
-51,560 Reduced 92.97%
3,901 $426 Million
Q4 2012

Apr 08, 2024

SELL
N/A
-5,101 Closed
0 $0
Q2 2012

Apr 08, 2024

BUY
N/A
975 Added 23.63%
5,101 $527 Million
Q1 2012

Apr 08, 2024

SELL
N/A
-1,977 Reduced 32.39%
4,126 $300 Million
Q4 2011

Apr 08, 2024

BUY
N/A
364 Added 6.34%
6,103 $431 Million
Q3 2011

Apr 08, 2024

BUY
N/A
55 Added 0.97%
5,739 $409 Million
Q2 2011

Apr 08, 2024

SELL
N/A
-126 Reduced 2.17%
5,684 $496 Million
Q1 2011

Apr 08, 2024

SELL
N/A
-448 Reduced 7.16%
5,810 $505 Million
Q4 2010

Apr 08, 2024

SELL
N/A
-49,203
6,258 $506 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.